FMRI neurofeedback: Novel interventions for depression

FMRI neurofeedback: Novel interventions for depression Kymberly Young, an Associate Professor of Psychiatry at the University of Pittsburgh School of Medicine, discusses neurofeedback as a novel non-invasive intervention for depression. Major depressive disorder (MDD) is a chronic, disabling, and devastation condition that is the leading cause of disability worldwide (Friedrich, 2017). Up to two-thirds of patients who seek standard interventions will not respond, while only one-half of patients who do will achieve sustained remission (Cain, 2007). Therefore, there is a pressing need to research and develop novel non-invasive interventions for MDD, particularly in those who have failed to respond to previous treatments such as antidepressant medications.